.png?w=1920&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=8E5D93C6681C8E636F3DD61D93B7739E)
Join Croda Pharma at CPHI Middle east 2024: Discover our latest innovations and smart science
We're exhibiting at CPHI Middle East 2024, booth 3,B4, Riyadh, Saudi Arabia on 10th-12th December
CPHI Middle East 2024 will be held from 10 - 12 December at Riyadh Front Exhibition and Convention Centre in Riyadh, Saudi Arabia. This event brings together the global pharmaceutical community, featuring over 400 exhibitors and around 30,000 attendees from more than 100 countries. The focus this year includes emerging technologies in R&D and manufacturing, sustainability initiatives, and innovations in packaging and drug delivery.
Our colleagues from around the world will join in Riyadh, Saudi Arabia for three days of learning, networking and customer meetings. We welcome you to connect with us via the CPHI event planner app, or on LinkedIn!
We're excited to share what we've been up to, here are just some of our latest launches and innovations:
- An expanded lipids offering with a range of highly purified phosphatidylcholine products originated from soybean and egg yolk - Natraphos™
- A product line extension of Super Refined™ DMI - Super Refined™ DMI-P is a highly purified solubiliser, epidermal penetration enhancer and spreading agent, with a preservative to enhance pH stability and extend shelf life for the excipient and finished product
- A new range of bioprocessing agents, Virodex™. Perfect for viral inactivation and cell lysis, Virodex™ is REACH-compliant, compendial, sustainable, and has been optimised for use in biomanufacturing of recombinant proteins, blood fractionation products, viral vectors, and more
- Sustainably sourced Squalene for vaccines - non-shark derived, and engineered by synthetic biology
- And more!
The path to decarbonisation
Visit our booth to learn about our continued commitment to sustainability through our decarbonisation journey. We are committed to achieving net zero and as such have verified Science Based Targets in line with restricting global warming to 1.5°C above the pre-industrial average. Read more here.
BOOK A MEETING BELOW
Super Refined™ Poloxamer 188
Super Refined™ Poloxamer 188 is added to cell culture media to protect cells from shear stress caused by agitation in a bioreactor. Super Refined™ Poloxamer 188 has been optimised specifically for mammalian cell culture with tightly controlled impurity profiles and molecular weight, ensuring optimal cell culture performance and batch-to-batch consistency.
Product Carbon Footprint data now available!
Product Carbon Footprint (PCF) is the total GHG emissions produced and consumed over the lifecycle of the product.
Event type: Conference
CPHI Middle East 2024
Join Croda Pharma at CPHI Europe 2024: Discover our latest innovations and smart science! This event brings together the global pharmaceutical community, featuring over 400+ exhibitors and around 30,000 attendees from 100+ countries. The focus is largely on biopharma, emerging technologies in R&D and manufacturing, sustainability initiatives, and innovations in packaging and drug delivery.
